A detailed history of Lipe & Dalton transactions in Danaher Corp stock. As of the latest transaction made, Lipe & Dalton holds 21,649 shares of DHR stock, worth $5.26 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares
21,649
Previous 22,375 3.24%
Holding current value
$5.26 Million
Previous $5.59 Million 3.19%
% of portfolio
2.91%
Previous 2.88%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$235.51 - $267.98 $170,980 - $194,553
-726 Reduced 3.24%
21,649 $5.41 Million
Q1 2024

May 07, 2024

SELL
$224.58 - $256.19 $7,860 - $8,966
-35 Reduced 0.16%
22,375 $5.59 Million
Q2 2023

Jul 26, 2023

SELL
$224.99 - $256.14 $89,996 - $102,456
-400 Reduced 1.75%
22,410 $5.38 Million
Q1 2023

May 02, 2023

SELL
$239.75 - $277.0 $245,743 - $283,925
-1,025 Reduced 4.3%
22,810 $5.75 Million
Q4 2022

Feb 03, 2023

SELL
$241.42 - $282.29 $27,763 - $32,463
-115 Reduced 0.48%
23,835 $6.33 Million
Q3 2022

Nov 07, 2022

BUY
$247.06 - $1507.4 $61,765 - $376,850
250 Added 1.05%
23,950 $6.19 Million
Q2 2022

Aug 01, 2022

SELL
$237.11 - $299.66 $11,855 - $14,983
-50 Reduced 0.21%
23,700 $6.01 Million
Q1 2022

Apr 26, 2022

SELL
$257.27 - $315.76 $317,728 - $389,963
-1,235 Reduced 4.94%
23,750 $6.97 Million
Q4 2021

Feb 01, 2022

BUY
$292.08 - $329.01 $92,589 - $104,296
317 Added 1.29%
24,985 $8.22 Million
Q3 2021

Nov 01, 2021

BUY
$272.21 - $332.43 $111,606 - $136,296
410 Added 1.69%
24,668 $7.51 Million
Q2 2021

Aug 02, 2021

SELL
$225.08 - $271.69 $13,504 - $16,301
-60 Reduced 0.25%
24,258 $6.51 Million
Q1 2021

Apr 30, 2021

SELL
$212.38 - $245.9 $175,213 - $202,867
-825 Reduced 3.28%
24,318 $5.47 Million
Q4 2020

Jan 29, 2021

SELL
$212.5 - $245.46 $72,250 - $83,456
-340 Reduced 1.33%
25,143 $5.59 Million
Q3 2020

Oct 30, 2020

SELL
$177.16 - $215.33 $52,262 - $63,522
-295 Reduced 1.14%
25,483 $5.49 Million
Q2 2020

Aug 07, 2020

SELL
$128.7 - $176.83 $36,036 - $49,512
-280 Reduced 1.07%
25,778 $4.56 Million
Q1 2020

May 01, 2020

SELL
$121.39 - $169.05 $126,245 - $175,812
-1,040 Reduced 3.84%
26,058 $3.61 Million
Q4 2019

Jan 21, 2020

SELL
$133.47 - $153.48 $4,004 - $4,604
-30 Reduced 0.11%
27,098 $4.16 Million
Q3 2019

Nov 07, 2019

SELL
$135.4 - $146.47 $1.1 Million - $1.19 Million
-8,128 Reduced 23.05%
27,128 $3.92 Million
Q2 2019

Jul 24, 2019

SELL
$124.88 - $143.73 $16,234 - $18,684
-130 Reduced 0.37%
35,256 $5.04 Million
Q1 2019

Apr 30, 2019

SELL
$97.62 - $132.29 $122,025 - $165,362
-1,250 Reduced 3.41%
35,386 $4.67 Million
Q4 2018

Feb 08, 2019

SELL
$94.85 - $109.54 $20,108 - $23,222
-212 Reduced 0.58%
36,636 $3.78 Million
Q3 2018

Nov 05, 2018

SELL
$98.13 - $108.9 $39,252 - $43,560
-400 Reduced 1.07%
36,848 $4 Million
Q2 2018

Aug 06, 2018

SELL
$96.1 - $103.24 $91,775 - $98,594
-955 Reduced 2.5%
37,248 $3.68 Million
Q1 2018

May 04, 2018

SELL
$92.16 - $103.8 $81,377 - $91,655
-883 Reduced 2.26%
38,203 $3.74 Million
Q4 2017

Feb 13, 2018

SELL
$85.26 - $94.62 $64,371 - $71,438
-755 Reduced 1.9%
39,086 $3.63 Million
Q3 2017

Nov 03, 2017

SELL
$79.29 - $88.45 $40,834 - $45,551
-515 Reduced 1.28%
39,841 $3.42 Million
Q2 2017

Aug 08, 2017

BUY
N/A
40,356
40,356 $3.41 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Lipe & Dalton Portfolio

Follow Lipe & Dalton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.